It seems they haven't actually lodged the FDA submission yet, but even so expect it to be approved early 2020. On the bright side, it must be an extremely thorough process, involve extensive trials in the US and will surely give them the credibility to attract customers. Ultimately, attracting major contracts overseas is what will increase the value of the co (although there's still plenty of potential to expand domestically since they're bringing other tests online still).
I thought it was a terrific result. It will take a little while still to get major sales in Europe as they have only just appointed sales team and signing contracts can take a while.
- Forums
- ASX - By Stock
- GSS
- Ann: Appendix 4C and quarterly update
GSS
genetic signatures limited
Add to My Watchlist
0.00%
!
36.5¢

Ann: Appendix 4C and quarterly update, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.90M |
Open | High | Low | Value | Volume |
36.5¢ | 36.5¢ | 36.5¢ | $657 | 1.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11082 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 45991 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11082 | 0.365 |
3 | 10907 | 0.360 |
4 | 130509 | 0.350 |
1 | 1683 | 0.300 |
1 | 25000 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 45991 | 2 |
0.390 | 20000 | 1 |
0.400 | 111918 | 2 |
0.420 | 40000 | 2 |
0.455 | 5000 | 1 |
Last trade - 10.22am 08/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |